Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha Interferon in AIDS-Related Progressive Multifocal Leukoencephalopathy.

T Counihan1, N Venna, D Craven

  • 1, Neurology Research, Warren 408, Massachusetts General Hospital, Fruit Street, Boston, MA, 02114.

Journal of Neuro-Aids
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diversity-Elevation Relationships of Vascular Plants in Austral Temperate Ecosystems Are Strata Dependent.

Ecology and evolution·2025
Same author

MRI Shrimp Sign in Cerebellar Progressive Multifocal Leukoencephalopathy: Description and Validation of a Novel Observation.

AJNR. American journal of neuroradiology·2021
Same author

Superficial Siderosis.

Irish medical journal·2016
Same author

Is it important to classify ischaemic stroke?

Irish medical journal·2012
Same author

A note on the effect of training on the physique of adolescent boys.

Clinical proceedings·2010
Same author

Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil.

Journal of neurology·2010
Same journal

Regional quantitative comparison of multispliced to unspliced ratios of HIV-1 RNA copy number in infected human brain.

Journal of neuro-AIDS·2006
Same journal

Transforming growth factor beta and monocyte chemotactic protein-1 are elevated in cerebrospinal fluid of immunocompromised patients with HIV-1 infection.

Journal of neuro-AIDS·2006
Same journal

Intracerebroventricular infusions of gp120 inhibit weight gain and induce atrophy in the hippocampus and neostriatum without affecting cognition.

Journal of neuro-AIDS·2006
Same journal

Manifestations of SIV-induced ocular pathology in macaque monkeys.

Journal of neuro-AIDS·2006
Same journal

Memory implications of a "fornix white line" in HIV infection.

Journal of neuro-AIDS·2006
Same journal

Degenerative and inflammatory lesions in sympathetic ganglia: further morphological evidence for an autonomic neuropathy in AIDS.

Journal of neuro-AIDS·2006
See all related articles

Recombinant interferon alpha showed no efficacy in treating progressive multifocal leukoencephalopathy (PML) in patients with acquired immunodeficiency syndrome (AIDS). This study found no clinical improvement or extended survival in these patients.

Area of Science:

  • Neurovirology
  • Immunology
  • Infectious Diseases

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease.
  • PML is often associated with the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS).
  • Recombinant interferon alpha has shown anecdotal efficacy in non-AIDS related PML.

Purpose of the Study:

  • To evaluate the effectiveness of recombinant interferon alpha for treating AIDS-associated PML.
  • To assess clinical response and survival rates in PML patients receiving interferon alpha therapy.

Main Methods:

  • An open-label, uncontrolled study was conducted.
  • Four consecutive AIDS patients with pathologically confirmed PML were enrolled.
  • Patients received daily subcutaneous recombinant interferon alpha (5-10 million units) for 4-12 weeks.

Related Experiment Videos

Main Results:

  • No patient demonstrated any clinical improvement with interferon alpha treatment.
  • The average survival time for the patients was 14 weeks.
  • No adverse side effects were reported during the treatment period.

Conclusions:

  • Recombinant interferon alpha appears to be ineffective for treating PML in AIDS patients.
  • The findings contradict anecdotal evidence from non-AIDS related PML cases.
  • Further research may be needed to explore alternative treatments for AIDS-related PML.